Prolor

Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'
Seeking Alpha
Wed, 11/21/12 - 11:15 am
Teva
M&A
Bristol-Myers Squibb
Eli Lilly
Novartis
Prolor
Pfizer
Prolor Biotech Is Worth An Investor's Research
Seeking Alpha
Thu, 07/12/12 - 07:34 pm
Prolor
Prolor Biotech: A Good Leadership Team That Can Make A Company Profitable
Seeking Alpha
Thu, 07/5/12 - 05:24 pm
Prolor
Prolor Biotech Receives A Boost On Data Presentation
Seeking Alpha
Thu, 06/28/12 - 10:46 am
Prolor
hGH-CTP
Merck
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Sat, 05/19/12 - 12:36 pm
Halozyme
Novavax
Prolor
Valeant Pharmaceuticals
Myrexis
OPKO Health
Vertex Pharmaceuticals
Edwards Lifesciences
Medivation
Biomarin
Mylan
PROLOR Biotech Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
Yahoo/PR NewsWire
Sat, 04/21/12 - 12:01 pm
Prolor
Prolor Biotech's Phase II Initiation Has Profound Pipeline Implications
Seeking Alpha
Mon, 03/26/12 - 12:16 pm
Prolor
hGH-CTP
President Of Prolor Biotech Bullish About His Firm's Pipeline And Positioning
Seeking Alpha
Mon, 02/27/12 - 04:42 pm
Prolor
Medgenics' Disruptive Biotechnology Is One To Watch
Seeking Alpha
Wed, 02/8/12 - 03:13 pm
Medgenics
Amgen
Prolor
Bristol-Myers Squibb
Protalix BioTherapeutics
2 Biotechs On Teva's Radar Screen
Seeking Alpha
Mon, 02/6/12 - 11:21 am
Teva Pharmaceuticals
Cel-Sci
Bristol-Myers Squibb
Prolor
2 Pharmaceutical Stocks Ready To Move
Seeking Alpha
Mon, 01/23/12 - 09:52 am
Amylin
Prolor
Why Prolor Biotech Is Rising And Other Attractive Prospects
Seeking Alpha
Fri, 01/20/12 - 09:55 am
Prolor
Abbott Laboratories
Alnylam
GSK
Merck
Pfizer
Lilly
Roche
Prolor Biotech: A Potentially Attractive Takeover Target
Seeking Alpha
Tue, 01/17/12 - 11:44 am
Prolor
M&A
5 Potential Big Movers In Pharma For 2012
Seeking Alpha
Thu, 12/22/11 - 06:45 am
CytoSorbents
Dendreon
Lpath
SIGA technologies
Prolor
Biotechs Rally on Bet Protalix to Win Approval: Israel Overnight
Mon, 10/24/11 - 09:15 pm
biotech
Israel
Prolor
Protalix BioTherapeutics
Prolor jumps 11% in wake of analyst reports
Marketwatch
Wed, 07/13/11 - 11:38 am
Prolor
Prolor Biotech: Interim Phase 2 Data Promising
Seeking Alpha
Mon, 06/20/11 - 10:04 am
Prolor
human growth hormone
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha
Sat, 04/9/11 - 11:02 am
Prolor
Lexicon Pharmaceuticals
Dendreon
Human Genome Sciences
Targacept
Sequenom
Cadence Pharmaceuticals
Savient
ONYX Pharmaceuticals
Amylin
Emergent BioSolutions
XenoPort
Spectrum Pharmaceuticals
Incyte
Amgen
12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors
Motley Fool
Sat, 02/26/11 - 10:21 am
Achillion
Aeterna Zentaris
AVI BioPharma
Cadence Pharmaceuticals
Cambrex Corp
Obagi Medical Products
Oncolytics
Osiris Therapeutics
PharmAthene
Prolor
Rexahn
Zalicus
Prolor Biotech: Will Phase 2 Growth Hormone Results Bring Uptick?
Seeking Alpha
Wed, 02/23/11 - 10:27 pm
growth hormone
Prolor

Pages